락토바실루스 플란타룸 관련 과민성 대장 증후군(IBS)

References

1. [1] Roman Maslennikov et al.. J Clin Med. 2026. Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome. doi:10.3390/jcm15031152 PubMed
2. [2] Theodore Rokkas et al.. Eur J Gastroenterol Hepatol. 2026. Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable bowel syndrome: a systematic review … doi:10.1097/MEG.0000000000003062 PubMed
3. [3] Nazila Dardmeh et al.. J Sci Food Agric. 2026. Effect of probiotic administration of Bifidobacterium animalis subsp. lactis BB-12 and Lactiplantibacillus plantarum ATCC 14917 on metabolic profiles in an … doi:10.1002/jsfa.70190 PubMed
4. [4] Qi Yao et al.. Nutrients. 2025. Lactobacillus plantarum and Galacto-Oligosaccharides Synbiotic Relieve Irritable Bowel Syndrome by Reshaping Gut Microbiota and Attenuating Mast Cell Hyperactivation. doi:10.3390/nu17101670 PubMed
5. [5] Anne Fennessy et al.. World J Gastrointest Pharmacol Ther. 2025. Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation … doi:10.4292/wjgpt.v16.i2.101268 PubMed
6. [6] Lim Song et al.. J Microbiol Biotechnol. 2025. Synergistic Modulation of the Gut-Brain-Immune Axis by a Dual Lactobacillus Combination in a Murine IBS Model. doi:10.4014/jmb.2507.07018 PubMed
7. [7] L Drago et al.. Benef Microbes. 2025. A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of irritable bowel syndrome in adults. doi:10.1163/18762891-bja00097 PubMed
8. [8] Hongyun Zhang et al.. Food Funct. 2024. Lactobacillus plantarum AR495 improves colonic transport hyperactivity in irritable bowel syndrome through tryptophan metabolism. doi:10.1039/d4fo01087f PubMed
9. [9] Pauline Jouët et al.. Minerva Gastroenterol (Torino). 2024. Probiotics plus vitamin D in irritable bowel syndrome: a prospective multicentric non-interventional study. doi:10.23736/S2724-5985.24.03581-2 PubMed
10. [10] Young Hoon Chang et al.. J Neurogastroenterol Motil. 2024. Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study. doi:10.5056/jnm23036 PubMed
11. [11] Olga Biskou et al.. Front Med (Lausanne). 2024. ReFerm®: a postbiotic fermented oat gruel composition is reducing mast cell degranulation in the colon of patients with irritable bowel … doi:10.3389/fmed.2024.1408623 PubMed
12. [12] Sarvesh V Surve et al.. J Appl Microbiol. 2024. Laboratory domestication of Lactiplantibacillus plantarum alters some phenotypic traits but causes non-novel genomic impact. doi:10.1093/jambio/lxae035 PubMed
13. [13] Vivek C Goodoory et al.. Gastroenterology. 2023. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. doi:10.1053/j.gastro.2023.07.018 PubMed
14. [14] Vivek C Goodoory et al.. Drugs. 2023. Antibiotics and Probiotics for Irritable Bowel Syndrome. doi:10.1007/s40265-023-01871-y PubMed
15. [15] Hee-Young Kim et al.. Food Nutr Res. 2022. Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study. doi:10.29219/fnr.v66.8268 PubMed
16. [16] Seung Yong Shin et al.. J Neurogastroenterol Motil. 2022. Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: … doi:10.5056/jnm21202 PubMed
17. [17] Kyoungmi Jung et al.. Nutrients. 2022. Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. doi:10.3390/nu14102015 PubMed
18. [18] Olga Bednarska et al.. Front Nutr. 2022. A postbiotic fermented oat gruel may have a beneficial effect on the colonic mucosal barrier in patients with irritable bowel … doi:10.3389/fnut.2022.1004084 PubMed
19. [19] Moeen-Ul-Haq et al.. J Pak Med Assoc. 2022. Role of Lactobacillus plantarum 299v versus Placebo in symptomatic improvement of irritable bowel syndrome patients. doi:10.47391/JPMA.0758 PubMed
20. [20] E Arvidsson Nordström et al.. Benef Microbes. 2021. Lactiplantibacillus plantarum 299v (LP299V®): three decades of research. doi:10.3920/BM2020.0191 PubMed
21. [21] Bo Yang et al.. Front Immunol. 2021. Lactobacillus plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double-Blind, Randomized, Placebo-Controlled Study. doi:10.3389/fimmu.2021.746585 PubMed
22. [22] Haiyan Xu et al.. Eur J Nutr. 2021. Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome. doi:10.1007/s00394-020-02437-4 PubMed
23. [23] Luisa Marras et al.. Microorganisms. 2021. The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia. doi:10.3390/microorganisms9040836 PubMed
24. [24] Diego A Barraza-Ortiz et al.. Dig Dis. 2021. Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: … doi:10.1159/000510950 PubMed
25. [25] Yang Liu et al.. Food Funct. 2021. Evidence from comparative genomic analyses indicating that Lactobacillus-mediated irritable bowel syndrome alleviation is mediated by conjugated linoleic acid synthesis. doi:10.1039/d0fo02616f PubMed
26. [26] Prapaporn Boonma et al.. Front Pain Res (Lausanne). 2021. Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome. doi:10.3389/fpain.2021.691689 PubMed
27. [27] Wojciech Marlicz et al.. Prz Gastroenterol. 2021. Probiotics in irritable bowel syndrome - is the quest for the right strain over? Rapid review of existing guidelines and … doi:10.5114/pg.2021.111766 PubMed
28. [28] Karolina Kaźmierczak-Siedlecka et al.. Cent Eur J Immunol. 2020. The role of Lactobacillus plantarum 299v in supporting treatment of selected diseases. doi:10.5114/ceji.2020.101515 PubMed
29. [29] Alberto Saccarello et al.. Prim Care Companion CNS Disord. 2020. Oral Administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 Improves the Mild-To-Moderate Symptoms of Depression: A Randomized, Double-Blind, Placebo-Controlled Study. doi:10.4088/PCC.19m02578 PubMed
30. [30] Karolina Kaźmierczak-Siedlecka et al.. Nutr J. 2020. The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a … doi:10.1186/s12937-020-00598-w PubMed
31. [31] K Kaźmierczak-Siedlecka et al.. Eur Rev Med Pharmacol Sci. 2020. Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in … doi:10.26355/eurrev_202009_23059 PubMed
32. [32] Yen-Wenn Liu et al.. Probiotics Antimicrob Proteins. 2020. Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis. doi:10.1007/s12602-019-09595-w PubMed
33. [33] Konstantinos Leventogiannis et al.. Probiotics Antimicrob Proteins. 2019. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth. doi:10.1007/s12602-018-9401-3 PubMed
34. [34] Ewa Pejcz et al.. Foods. 2019. Technological Methods for Reducing the Content of Fructan in Wheat Bread. doi:10.3390/foods8120663 PubMed
35. [35] Luigi Bonavina et al.. Acta Biomed. 2019. Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with … doi:10.23750/abm.v90i7-S.8649 PubMed
36. [36] Elsa Sandberg Nielsen et al.. Food Funct. 2018. Lacto-fermented sauerkraut improves symptoms in IBS patients independent of product pasteurisation - a pilot study. doi:10.1039/c8fo00968f PubMed
37. [37] Jin Young Yoon et al.. Dig Dis Sci. 2018. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study. doi:10.1007/s10620-018-5139-8 PubMed
38. [38] I Presti et al.. Appl Microbiol Biotechnol. 2015. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect. doi:10.1007/s00253-015-6482-8 PubMed
39. [39] Cheryl Stevenson et al.. Nutrition. 2014. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. doi:10.1016/j.nut.2014.02.010 PubMed
40. [40] María Ortiz-Lucas et al.. Rev Esp Enferm Dig. 2013. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. doi:10.4321/s1130-01082013000100005 PubMed
41. [41] Marina L Ritchie et al.. PLoS One. 2012. A meta-analysis of probiotic efficacy for gastrointestinal diseases. doi:10.1371/journal.pone.0034938 PubMed
42. [42] Philippe Ducrotté et al.. World J Gastroenterol. 2012. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. doi:10.3748/wjg.v18.i30.4012 PubMed
43. [43] Bong Ki Cha et al.. J Clin Gastroenterol. 2012. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, … doi:10.1097/MCG.0b013e31823712b1 PubMed
44. [44] Wojciech Marlicz et al.. Pol Merkur Lekarski. 2012. [Irritable bowel syndrome--irritable bowel or irritable mind?]. PubMed
45. [45] M Bixquert Jiménez. Rev Esp Enferm Dig. 2009. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? doi:10.4321/s1130-01082009000800006 PubMed
46. [46] Martin H Floch. J Clin Gastroenterol. 2005. Use of diet and probiotic therapy in the irritable bowel syndrome: analysis of the literature. doi:10.1097/01.mcg.0000156104.67505.5b PubMed
47. [47] H-J Krammer et al.. Z Gastroenterol. 2005. [Probiotics as therapeutic agents in irritable bowel syndrome]. doi:10.1055/s-2004-813934 PubMed
48. [48] Alfredo Saggioro. J Clin Gastroenterol. 2004. Probiotics in the treatment of irritable bowel syndrome. doi:10.1097/01.mcg.0000129271.98814.e2 PubMed
49. [49] Anthony G Wynne et al.. Anaerobe. 2004. An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a … doi:10.1016/j.anaerobe.2004.03.002 PubMed
50. [50] S Sen et al.. Dig Dis Sci. 2002. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. doi:10.1023/a:1020597001460 PubMed
51. [51] Joel A. Sach et al.. Curr Treat Options Gastroenterol. 2002. Irritable Bowel Syndrome. doi:10.1007/s11938-002-0049-3 PubMed
52. [52] K Niedzielin et al.. Eur J Gastroenterol Hepatol. 2001. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. doi:10.1097/00042737-200110000-00004 PubMed
53. [53] S Nobaek et al.. Am J Gastroenterol. 2000. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. doi:10.1111/j.1572-0241.2000.02015.x PubMed